Urology
Volume 71, Issue 3 , Pages 395-398 , March 2008

Relationship of Prostate-Specific Antigen and Prostate Volume in Korean Men with Biopsy-Proven Benign Prostatic Hyperplasia

  • Sang Eun Lee

      Affiliations

    • Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Jae Seung Chung

      Affiliations

    • Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Byung Kyu Han

      Affiliations

    • Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Ki Hyuk Moon

      Affiliations

    • Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Sung Il Hwang

      Affiliations

    • Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Hak Jong Lee

      Affiliations

    • Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Gheeyoung Choe

      Affiliations

    • Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea
    • ,
  • Sung Kyu Hong

      Affiliations

    • Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
    • Corresponding Author InformationReprint requests: Sung Kyu Hong, M.D., Ph.D., Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam, Kyunggi-do, Korea 463-707.

Received 10 June 2007 ,Accepted 19 October 2007.

References 

  1. Wang MC, Valenzuela LA, Murphy GP, et al. Purification of a human prostate specific antigen. Invest Urol. 1979;17:159–163
  2. Roehrborn CG, Boyle P, Gould AL, et al. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology. 1999;53:581–589
  3. Roehrborn CG, McConnell JD, Lieber M, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia (PLESS Study Group). Urology. 1999;53:473–480
  4. Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–487
  5. Roehrborn CG, Boyle P, Bergner D, et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo (PLESS Study Group). Urology. 1999;54:662–669
  6. Roehrborn CG, Boyle P, Nickel JC, et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 2002;60:434–441
  7. Gupta A, Aragaki C, Gotoh M, et al. Relationship between prostate specific antigen and indexes of prostate volume in Japanese men. J Urol. 2005;173:503–506
  8. Chang YL, Lin AT, Chen KK, et al. Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia. J Urol. 2006;176:196–199
  9. Hochberg DA, Armenakas NA, Fracchia JA. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate. 2000;45:315–319
  10. Masumori N, Tsukamoto T, Kumamoto Y, et al. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol. 1996;155:1324–1327
  11. Oesterling JE, Kumamoto Y, Tsukamoto T, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol. 1995;75:347–353
  12. Shim HB, Lee JK, Jung TY, Ku JH. Serum prostate specific antigens a predictor of prostate volume in Korean men with lower urinary tract symptoms. Prostate Cancer Prostatic Dis. 2007;10:143–148
  13. Berry SJ, Coffey DS, Ewing LL. Effects of aging on prostate growth in beagles. Am J Physiol. 1986;250:R1039–R1046
  14. Walsh PC, Madden JD, Harrod MJ, et al. Familial incomplete male pseudohermaphroditism, type 2: decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 1974;291:944–949
  15. Roberts RO, Bergstralh EJ, Cunningham JM, et al. Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol. 2004;159:269–276
  16. Wu AH, Whittemore AS, Kolonel LN, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev. 1995;4:735–741
  17. Platz EA, Rimm EB, Willett WC, et al. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst. 2000;92:2009–2017
  18. Lepor H, Shapiro E, Wang B, et al. Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and caucasian-american men. Urology. 1996;47:38–42
  19. Aoki Y, Arai Y, Maeda H, et al. Racial differences in cellular composition of benign prostatic hyperplasia. Prostate. 2001;49:243–250

PII: S0090-4295(07)02269-8

doi: 10.1016/j.urology.2007.10.019

Urology
Volume 71, Issue 3 , Pages 395-398 , March 2008

Article Tools

* Image Usage & Resolution